Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Julia Mersi"'
Autor:
Umair Munawar, Johanna Theuersbacher, Maximilian J. Steinhardt, Xiang Zhou, Seungbin Han, Silvia Nerreter, Cornelia Vogt, Shilpa Kurian, Thorsten Keller, Ann-Katrin Regensburger, Eva Teufel, Julia Mersi, Max Bittrich, Franziska Seifert, Malik S. Haider, Leo Rasche, Jost Hillenkamp, Hermann Einsele, Daniel Kampik, K. Martin Kortüm, Johannes M. Waldschmidt
Publikováno v:
Haematologica, Vol 109, Iss 11 (2024)
Externí odkaz:
https://doaj.org/article/09c3d7b2071d4832b1033ee4fc16cf6d
Autor:
Umair Munawar, Xiang Zhou, Sabrina Prommersberger, Silvia Nerreter, Cornelia Vogt, Maximilian J. Steinhardt, Marietta Truger, Julia Mersi, Eva Teufel, Seungbin Han, Larissa Haertle, Nicole Banholzer, Patrick Eiring, Sophia Danhof, Miguel Angel Navarro-Aguadero, Adrian Fernandez-Martin, Alejandra Ortiz-Ruiz, Santiago Barrio, Miguel Gallardo, Antonio Valeri, Eva Castellano, Peter Raab, Maximilian Rudert, Claudia Haferlach, Markus Sauer, Michael Hudecek, J. Martinez-Lopez, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, K. Martin Kortüm
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-9 (2023)
Abstract The treatment landscape in multiple myeloma (MM) is shifting from genotoxic drugs to immunotherapies. Monoclonal antibodies, immunoconjugates, T-cell engaging antibodies and CART cells have been incorporated into routine treatment algorithms
Externí odkaz:
https://doaj.org/article/91aba52b6c244a118ef7a4278eff963f
Autor:
Umair Munawar, Johanna Theuersbacher, Maximilian J. Steinhardt, Xiang Zhou, Seungbin Han, Silvia Nerreter, Cornelia Vogt, Shilpa Kurian, Thorsten Keller, Ann-Katrin Regensburger, Eva Teufel, Julia Mersi, Max Bittrich, Franziska Seifert, Malik S. Haider, Leo Rasche, Jost Hillenkamp, Hermann Einsele, Daniel Kampik, K. Martin Kortüm, Johannes M. Waldschmidt
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Belantamab mafodotin (belantamab) is a first-in-class anti-BCMA antibody-drug conjugate approved for the treatment of triple-class refractory multiple myeloma. It provides a unique therapeutic option for patients ineligible for CAR-T and bispecific a
Externí odkaz:
https://doaj.org/article/5b70ffdb59ff4ed5b400827482becc1e
Autor:
Xiang Zhou, Seungbin Han, Nadine Cebulla, Larissa Haertle, Maximilian J. Steinhardt, Daniel Schirmer, Eva Runau, Leon Flamm, Calvin Terhorst, Laura Jähnel, Cornelia Vogt, Silvia Nerreter, Eva Teufel, Emilia Stanojkovska, Julia Mersi, Umair Munawar, Magnus Schindehütte, Robert Blum, Ann-Kristin Reinhold, Oliver Scherf-Clavel, Heike L. Rittner, Mirko Pham, Leo Rasche, Hermann Einsele, Claudia Sommer, K. Martin Kortüm
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-4 (2023)
Abstract We analyzed single nucleotide polymorphisms (SNPs) in PKNOX1 (rs2839629) and in the intergenic region between PKNOX1 and CBS (rs915854) by Sanger sequencing in 88 patients with multiple myeloma treated with bortezomib. All patients (n = 13)
Externí odkaz:
https://doaj.org/article/e043da7190114504a5058138355ee591
Autor:
Maximilian J. Steinhardt, Marietta Truger, Max Bittrich, Xiang Zhou, Julia Noderer, Christine Riedhammer, Xianghui Xiao, Sophia Gawlas, Philipp Weis, Florian Eisele, Claudia Haferlach, Julia Mersi, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, K. Martin Kortüm
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/4de0972e17f046038dc9063235362e22
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
The treatment of multiple myeloma (MM) is evolving rapidly. In the past few years, chimeric antigen receptor modified T cells and bispecific antibodies are bringing new treatment options to patients with relapsed/refractory MM. Currently, B-cell matu
Externí odkaz:
https://doaj.org/article/dc78d228034d43dcb980f98f261234ab
Autor:
Thomas Horvatits, Patrick Behrendt, Niels Schuebel, Martina Guthoff, Johannes Wiegand, Anna Harth, Julia Mersi, Marc Luetgehetmann, Clemence Gallon, Meike Rybczynski, Zhaochao Liang, Benjamin Maasoumy, Vincent Mallet, Lin Wang, Sven Pischke
Publikováno v:
Hepatitis Monthly. 23
Background: Chronic hepatitis E virus (HEV) infection may progress to end-stage liver disease in immunosuppressed individuals. Ribavirin therapy is efficient in most chronic HEV patients, but 10% remain without a sustained virological response (SVR).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66b0ccb4f2372fc1bd3437a132a33f94
https://doi.org/10.5812/hepatmon-130865
https://doi.org/10.5812/hepatmon-130865
Autor:
Xiang Zhou, Annika Hofmann, Cornelia Vogt, Silvia Nerreter, Eva Teufel, Emilia Stanojkovska, Marietta Truger, Benedict Engel, Anastasia Barcic, Jessica Peter, Christine Riedhammer, Max Johannes Steinhardt, Xianghui Xiao, Hannah Hornburger, Seungbin Han, Larissa Haertle, Umair Munawar, Julia Mersi, Claudia Haferlach, Hermann Einsele, Leo Rasche, K. Martin Kortuem
Publikováno v:
Blood. 140:4273-4274
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f129ee672878fafd9c66dd2d68b1b4f
https://doi.org/10.1182/blood-2022-163848
https://doi.org/10.1182/blood-2022-163848
Autor:
Alexander Leipold, Rudolf Werner, Johannes Duell, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Andreas Buck, Julia Mersi, Hermann Einsele, K. Martin Kortuem, Antoine-Emmanuel Saliba, Leo Rasche
Publikováno v:
Blood. 140:10020-10021
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7911c4a8a522f8df2c04ac2adeca6f87
https://doi.org/10.1182/blood-2022-168836
https://doi.org/10.1182/blood-2022-168836
Autor:
Max Johannes Steinhardt, Patrick Eiring, Umair Munawar, Larissa Haertle, Seungbin Han, Cornelia Vogt, Silvia Nerreter, Eva Teufel, Julia Mersi, Max Bittrich, Sophia Danhof, Marietta Truger, Thomas Haaf, Santiago Barrio, Xiang Zhou, Joaquín Martínez-López, Claudia Haferlach, Michael Hudecek, Hermann Einsele, Leo Rasche, Markus Sauer, K. Martin Kortuem
Publikováno v:
Blood. 140:4230-4231
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3784120451c5cd7767a75cd6551907ea
https://doi.org/10.1182/blood-2022-169255
https://doi.org/10.1182/blood-2022-169255